Pleurodesis outcome in malignant pleural mesothelioma

被引：43

作者：

Fysh, Edward Thomas Hamilton ^{[1
,2
]}

Tan, Sze Khen ^{[1
,3
]}

Read, Catherine Ann ^{[1
]}

Lee, Felicity ^{[1
]}

McKenzie, Kate ^{[1
]}

Olsen, Nola ^{[4
]}

Weerasena, Indunil ^{[1
]}

Threlfall, Timothy ^{[5
]}

de Klerk, Nicholas ^{[4
]}

Musk, A. William ^{[1
,4
]}

Lee, Y. C. Gary ^{[1
,2
]}

机构：

[1] Sir Charles Gairdner Hosp, Resp Dept, Perth, WA, Australia

[2] Univ Western Australia, Dept Med, Sch Med & Pharmacol, Ctr Asthma Allergy & Resp Res, Perth, WA 6009, Australia

[3] Khoo Teck Puat Hosp, Dept Gen Med, Singapore, Singapore

[4] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia

[5] Western Australia Dept Hlth, Western Australian Canc Registry, Mt Claremont, WA, Australia

来源：

THORAX | 2013年 / 68卷 / 06期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1136/thoraxjnl-2012-203043

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Few data exist on the pleurodesis outcome in patients with malignant pleural mesothelioma (MPM). A retrospective review of the Western Australian Mesothelioma Registry over 5 years revealed 390 evaluable patients. Only a subset of patients (42.3%) underwent pleurodesis, surgically (n=78) or by bedside instillation of sclerosants (n=87). Surgical pleurodesis showed no advantages over bedside pleurodesis in efficacy (32% vs 31% failures requiring further drainage, p=0.98), patient survival (p=0.52) or total time spent in hospital from procedure till death (p=0.36). No clinical, biochemical or radiographic parameters tested adequately predict pleurodesis outcome.

引用

页码：594 / 596

页数：3

共 50 条

[31] Malignant pleural mesothelioma
Chen, Sheree E.
Pace, Makala B.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2012, 69 (05) : 377 - 385
[32] Malignant Pleural Mesothelioma
Bois, Melanie C.
Lee, Hee Eun
Erickson, Lori A.
MAYO CLINIC PROCEEDINGS, 2016, 91 (07) : E103 - E104
[33] Malignant Pleural Mesothelioma
Siva Raja
Sudish C. Murthy
David P. Mason
Current Oncology Reports, 2011, 13 : 259 - 264
[34] Malignant pleural mesothelioma
Ceresoli, GL
Betta, GP
Castagneto, B
Facciolo, F
Arcangeli, G
Zucali, PA
Libener, R
De Giovanni, D
Melis, E
Mirri, MA
ANNALS OF ONCOLOGY, 2006, 17 : 13 - 16
[35] Malignant pleural mesothelioma
Hoogsteden, HC
Langerak, AW
vanderKwast, TH
Versnel, MA
vanGelder, T
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1997, 25 (02) : 97 - 126
[36] Malignant Pleural Mesothelioma
Ettinger, David S.
Akerley, Wallace
Borghaei, Hossein
Chang, Andrew
Cheney, Richard T.
Chirieac, Lucian R.
D'Amico, Thomas A.
Demmy, Todd L.
Ganti, Apar Kishor P.
Govindan, Ramaswamy
Grannis, Frederic W., Jr.
Horn, Leora
Jahan, Thierry M.
Jahanzeb, Mohammad
Kessinger, Anne
Komaki, Ritsuko
Kong, Feng-Ming
Kris, Mark G.
Krug, Lee M.
Lennes, Inga T.
Loo, Billy W., Jr.
Martins, Renato
O'Malley, Janis
Osarogiagbon, Raymond U.
Otterson, Gregory A.
Patel, Jyoti D.
Pinder-Schenck, Mary
Pisters, Katherine M.
Reckamp, Karen
Riely, Gregory J.
Rohren, Eric
Swanson, Scott J.
Wood, Douglas E.
Yang, Stephen C.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (01): : 26 - 41
[37] Malignant pleural mesothelioma
Hesdorffer, M. E.
Leinwand, J.
Taub, R. N.
JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2007, 37 (03): : 232 - 237
[38] Malignant Pleural Mesothelioma
Tsao, Anne S.
Wistuba, Ignacio
Roth, Jack A.
Kindler, Hedy Lee
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (12) : 2081 - 2090
[39] Malignant pleural mesothelioma
Pass, HI
Vogelzang, NJ
Hahn, S
Carbone, M
CURRENT PROBLEMS IN CANCER, 2004, 28 (03) : 85 - +
[40] Malignant pleural mesothelioma
Gross-Goupil, M
Ruffié, P
BULLETIN DU CANCER, 1999, : 43 - 54

← 1 2 3 4 5 →